Literature DB >> 33963379

Thyroid Hormone Deiodinases: Dynamic Switches in Developmental Transitions.

Arturo Hernandez1,2,3, M Elena Martinez1, Lily Ng4, Douglas Forrest4.   

Abstract

Thyroid hormones exert pleiotropic, essential actions in mammalian, including human, development. These actions depend on provision of thyroid hormones in the circulation but also to a remarkable extent on deiodinase enzymes in target tissues that amplify or deplete the local concentration of the primary active form of the hormone T3 (3,5,3'-triiodothyronine), the high affinity ligand for thyroid hormone receptors. Genetic analyses in mice have revealed key roles for activating (DIO2) and inactivating (DIO3) deiodinases in cell differentiation fates and tissue maturation, ultimately promoting neonatal viability, growth, fertility, brain development, and behavior, as well as metabolic, endocrine, and sensory functions. An emerging paradigm is how the opposing activities of DIO2 and DIO3 are coordinated, providing a dynamic switch that controls the developmental timing of a tissue response, often during neonatal and maturational transitions. A second paradigm is how cell to cell communication within a tissue determines the response to T3. Deiodinases in specific cell types, often strategically located near to blood vessels that convey thyroid hormones into the tissue, can regulate neighboring cell types, suggesting a paracrine-like layer of control of T3 action. We discuss deiodinases as switches for developmental transitions and their potential to influence tissue dysfunction in human thyroid disorders.
© The Author(s) 2021. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  central nervous system; deiodinase; development; neuroendocrine function; sensory system; thyroid hormone

Mesh:

Substances:

Year:  2021        PMID: 33963379      PMCID: PMC8248586          DOI: 10.1210/endocr/bqab091

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  127 in total

1.  Genomic imprinting of DIO3, a candidate gene for the syndrome associated with human uniparental disomy of chromosome 14.

Authors:  Maria Elena Martinez; David F Cox; Brian P Youth; Arturo Hernandez
Journal:  Eur J Hum Genet       Date:  2016-06-22       Impact factor: 4.246

2.  The Thyroid Hormone Inactivator Enzyme, Type 3 Deiodinase, Is Essential for Coordination of Keratinocyte Growth and Differentiation.

Authors:  Giuseppina Mancino; Annarita Sibilio; Cristina Luongo; Emery Di Cicco; Caterina Miro; Annunziata Gaetana Cicatiello; Annarita Nappi; Serena Sagliocchi; Raffaele Ambrosio; Maria Angela De Stefano; Daniela Di Girolamo; Tommaso Porcelli; Melania Murolo; Federica Saracino; Giuseppe Perruolo; Pietro Formisano; Mariano Stornaiuolo; Monica Dentice
Journal:  Thyroid       Date:  2020-04-29       Impact factor: 6.568

3.  Deficiency of type 2 iodothyronine deiodinase reduces necroptosis activity and oxidative stress responses in retinas of Leber congenital amaurosis model mice.

Authors:  Fan Yang; Hongwei Ma; Michael R Butler; Xi-Qin Ding
Journal:  FASEB J       Date:  2018-06-06       Impact factor: 5.191

4.  Reduced L- and M- and increased S-cone functions in an infant with thyroid hormone resistance due to mutations in the THRβ2 gene.

Authors:  Avery H Weiss; John P Kelly; Darren Bisset; Samir S Deeb
Journal:  Ophthalmic Genet       Date:  2012-05-02       Impact factor: 1.803

5.  Type 2 deiodinase polymorphism causes ER stress and hypothyroidism in the brain.

Authors:  Sungro Jo; Tatiana L Fonseca; Barbara M L C Bocco; Gustavo W Fernandes; Elizabeth A McAninch; Anaysa P Bolin; Rodrigo R Da Conceição; Joao Pedro Werneck-de-Castro; Daniele L Ignacio; Péter Egri; Dorottya Németh; Csaba Fekete; Maria Martha Bernardi; Victoria D Leitch; Naila S Mannan; Katharine F Curry; Natalie C Butterfield; J H Duncan Bassett; Graham R Williams; Balázs Gereben; Miriam O Ribeiro; Antonio C Bianco
Journal:  J Clin Invest       Date:  2018-12-03       Impact factor: 14.808

6.  Type 3 deiodinase deficiency results in functional abnormalities at multiple levels of the thyroid axis.

Authors:  Arturo Hernandez; M Elena Martinez; Xiao-Hui Liao; Jacqueline Van Sande; Samuel Refetoff; Valerie Anne Galton; Donald L St Germain
Journal:  Endocrinology       Date:  2007-09-06       Impact factor: 4.736

7.  Congenital hypothyroidism, dwarfism, and hearing impairment caused by a missense mutation in the mouse dual oxidase 2 gene, Duox2.

Authors:  Kenneth R Johnson; Coleen C Marden; Patricia Ward-Bailey; Leona H Gagnon; Roderick T Bronson; Leah Rae Donahue
Journal:  Mol Endocrinol       Date:  2007-04-17

8.  A Type 2 Deiodinase-Dependent Increase in Vegfa Mediates Myoblast-Endothelial Cell Crosstalk During Skeletal Muscle Regeneration.

Authors:  Xingxing An; Ashley Ogawa-Wong; Colleen Carmody; Raffaele Ambrosio; Annunziata Gaetana Cicatiello; Cristina Luongo; Domenico Salvatore; Diane E Handy; P Reed Larsen; Simone Magagnin Wajner; Monica Dentice; Ann Marie Zavacki
Journal:  Thyroid       Date:  2020-09-09       Impact factor: 6.568

9.  Epigenetic control of type 2 and 3 deiodinases in myogenesis: role of Lysine-specific Demethylase enzyme and FoxO3.

Authors:  Raffaele Ambrosio; Valentina Damiano; Annarita Sibilio; Maria Angela De Stefano; Vittorio Enrico Avvedimento; Domenico Salvatore; Monica Dentice
Journal:  Nucleic Acids Res       Date:  2013-02-08       Impact factor: 16.971

10.  Human Type 1 Iodothyronine Deiodinase (DIO1) Mutations Cause Abnormal Thyroid Hormone Metabolism.

Authors:  Monica M França; Alina German; Gustavo W Fernandes; Xiao-Hui Liao; Antonio C Bianco; Samuel Refetoff; Alexandra M Dumitrescu
Journal:  Thyroid       Date:  2020-09-29       Impact factor: 6.506

View more
  1 in total

Review 1.  Effects of Thyroid Hormones on Lipid Metabolism Pathologies in Non-Alcoholic Fatty Liver Disease.

Authors:  Chia-Jung Liao; Po-Shuan Huang; Hui-Tzu Chien; Tzu-Kang Lin; Chau-Ting Yeh; Kwang-Huei Lin
Journal:  Biomedicines       Date:  2022-05-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.